



PRESCRIBING PATTERN OF ANTIHYPERTENSIVE DRUGS BASED ON COMPELLING 
INDICATIONS WITH HYPERTENSION 
Original Article 
 
D. GIRI RAJASEKHAR1*, D. GURU PRASANNA1, P. CHANDRAKANTH
Department of Pharmacy Practice, Annamacharya College of Pharmacy, Rajampet 516126,Andhra Pradesh, India 
Email: giriraj.pharma@gmail.com  
1 
 Received: 21 May 2015 Revised and Accepted: 12 Dec 2015 
ABSTRACT 
Objective: The aim of the study is to assess the various prescribing patterns in hypertension with different compelling indications. 
Methods: It is a prospective observational study and carried out for a period of 1 y from Feb-2014 to Feb-2015. All the required data was collected 
from patients through personal interview and prescriptions. The data collected from the participants was entered into Microsoft excel spreadsheet 
and descriptive statistics were used. The mean and standard deviation (SD) were calculated. 
Results: A total of 394 hypertensive patients with different comorbidities were included in which 251(63.70%) males and 143(36.29%) females 
were present with a mean (SD) age of 59.21±1.54. The most commonly reported first three co-morbidities along with hypertension were diabetes 
mellitus 191 (48.47%), stroke accounts for 57 (14.46%) and coronary artery disease in 32 (8.12%). Monotherapy was given in almost 200 (50.76%) 
patients and dual drug therapy was indicated in 166 (42.13%) patients, triple therapy was used only in 24 (6.09%) patients in the total sample size. 
Quadruple therapy is the least preferred combination therapy accounts only in 4 (1.01%) patients. 
Conclusion: We conclude that calcium channel blockers and angiotensin II receptor blockers were the most commonly prescribed class of drugs 
either alone or in combination with other class of drugs for effective control of blood pressure patients with different compelling indications. 
Monotherapy was preferred than combination therapy.  
Keywords: Hypertension, Comorbidities, Prescribing patterns, Diabetes mellitus. 
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INTRODUCTION 
Worldwide prevalence estimates for hypertension may be as much 
as 1 billion individuals, and approximately 7.1 million deaths per 
year may be attributable to hypertension and its complications [1]. 
Hypertension has been identified as a major risk factor not only for 
the development of diabetes but also for the development of micro 
and macrovascular complications that is, neuropathy, nephropathy, 
retinopathy, coronary artery disease (CAD), stroke, peripheral 
vascular disease (PVD) in diabetic patients[2]. Drugs play an 
important role in protecting, maintaining and restoring health [3]. A 
prescription-based survey is considered to be one of the most 
effective methods to assess and evaluate the prescribing attitude of 
physicians [4]. A large number of antihypertensive drugs alone or in 
various combinations are available and physicians need to choose 
the most appropriate drug for a particular patient. The standard 
treatment guidelines and drug utilization studies at regular intervals 
help physicians to prescribe drugs rationally. A wide range of 
antihypertensive drugs belonging to different pharmacological 
classes are available such as Angiotensin Converting Enzyme 
inhibitors, Beta Blockers, Angiotensin Receptor Blockers, Calcium 
Channel Blockers, Diuretics, Alpha-adrenergic blockers and central 
sympatholytics. Choice of drugs for particular patient changes at 
short intervals because of factors like efficacy, side effects, cost and 
development of newer drugs. Recommendations of various expert 
groups regarding the choice of drugs are available as treatment 
guidelines to reduce practice variability, cost and improve rational 
pharmacotherapy. Implementation of these guidelines has been shown 
to be effective in raising the quality of antihypertensive therapy [5]. 
This study was designed to evaluate the prescribing pattern of 
antihypertensive drugs by physicians in patients with different co-
morbid conditions. We also assessed the most commonly prescribed 
class of drugs either alone or in combination with other class of 
drugs for effective control of blood pressure patients with different 
compelling indications. Failure to prescribe appropriate lifestyle 
modifications, adequate antihypertensive drug doses or appropriate 
drug combinations may result in inadequate BP control. The aim of 
the study is to assess the various prescribing patterns in 
hypertension with different compelling indications. 
MATERIALS AND METHODS 
Study design  
It is a prospective observational study.  
Study period 
The present study was carried out for a period of 1 y from Feb-2014 
to Feb-2015. 
Study site 
The present study was conducted at Rajiv Gandhi Institute of 
Medical Sciences (RIMS) at the inpatient department, Kadapa. 
Source of data 
All the patients satisfying the inclusion criteria were selected from 
medical inpatient and outpatient departments in Rajiv Gandhi 
institute of medical sciences (RIMS) Government Hospital, Kadapa. 
All the required data was collected from patients through personal 
interview and prescriptions.  
Sample size 
The total sample size was 394. 
Inclusion criteria 
• Patients of either sex are included 
• Age above 25 y 
• Patients with any co-morbidities 
Exclusion criteria 
• Pregnant women and children are excluded 
• Chronic kidney disease (CKD) patients are excluded  
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Method of collection of data 
All the patients satisfying the inclusion criteria were selected from 
inpatient medical departments in Rajiv Gandhi institute of medical 
sciences (RIMS) Government Hospital, Kadapa.  
Statistical analysis 
The data collected from the participants was entered into Microsoft 
excel spreadsheet and descriptive statistics were used. Mean and 
standard deviation (SD) were calculated. 
 
 
Fig. 1: Overview of the work 
 
RESULTS 
A total of 394 hypertensive patients with different comorbidities 
were included in which 251(63.70%) males and 143(36.29%) 
females were present with a mean (SD) age of 59.21±1.54as shown 
in table 1. 
 
Fig. 2: Percentage based on drug therapy 
Monotherapy was given in almost 200 (50.76%) patients and among 
them most commonly prescribed top two group of drug class were 
calcium channel blockers and angiotensin II receptor blockers which 
account for 50% and 32.5% respectively.  
Dual drug therapy was indicated in 166 (42.13%) patients and the 
most commonly prescribed dual therapy regimen were angiotensin 
II receptor blockers+calcium channel blockers in 27.71% followed 
by β blockers+calcium channel blockers in 20.48% and calcium 
channel blockers+diuretics in 19.27% along with different 
combinations as shown in the table 6. 
Triple therapy was used only in 24 (6.09%) patients in the total 
sample size. The most commonly prescribed triple therapy regimens 
were angiotensin II receptor blockers+calcium channel blockers+ 
diuretics in 33.3% followed by angiotensin II receptor blockers+ 
angiotensin converting enzyme inhibitors+diuretics in 25% along 
with other combinations as shown in the table 7. 
Quadruple therapy is the least preferred combination therapy 
accounts only in 4 (1.01%) patients. 
 
Table 1: Sample distribution based on gender 
Total patients with HTN  Male patients (%)  Female patients (%)  
394(100%) 251(63.70%) 143(36.29%) 
All the subjects with hypertension were categorized into different age groups to identify the commonly affected age group. Majority of patients were 
found to be in the age group of 56-65 y were 144 (36.80%), followed by 103 (26.14 %) in the people with>65 y, were represented in table 2. 
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Table 2: Different age groups in the study sample 
Age group (yrs)  No. of male patients  No. of female patients  Total No. of patients  
25-35y 3 3 6 
36-45y 23 20 43 
46-55y 53 45 98 
56-65y 100 44 144 
>65y 72 31 103 
Total 251 143 394 
 
Table 3: List of common Comorbidities in patients with hypertension 
Comorbidity No. of male patients  No. of female patients Total No. of patients  
DM 121 70 191 
CVA 40 17 57 
CAD 24 8 32 
CCF 11 6 17 
Others 58 39 97 
Hypertension is not a single disease that affects one system and it is the leading cause for many other diseases, therefore we have assessed various 
co-morbidities along with hypertension in the present study. The most commonly reported first three co-morbidities along with hypertension were 
diabetes mellitus 191 (48.47%), stroke accounts for 57 (14.46%) and coronary artery disease in 32 (8.12%). 
 
Table 4: Monotherapy and combination therapy 
Treatment No. of male patients  No. of female patients Total No. of patients  
Mono therapy 135 65 200(50.76%) 
Dual therapy 100 66 166(42.13%) 
Triple therapy 14 10 24 6(.09%) 
 Quadruple therapy 2 2 4(1.01%) 
 
Table 5: Different class of drugs commonly used in Monotherapy 
Class Dm Cva Cad Ccf Others Total 
Calcium channel blockers 41 10 5 5 39 100 
Angiotensin II receptor blocker 42 15 4 3 1 65 
ACE Inhibitors 7 4   2 13 
β blockers 15 3 4   22 
Total  105 32 13 8 42 200 
 
Table 6: Different class of drugs used in dual therapy 
Combination Dm Cva Cad Ccf Others Total 
A+C 28 10   8 46 
B+C 23 4 4 2 1 34 
C+E 7  1  4 12 
C+D 14 2 5 3 8 32 
C+F  1   9 10 
A+D 1 1 1  7 10 
B+D 1    2 3 
A+B 2 2  1 4 9 
E+D 2    1 3 
B+E 2   1  3 
A+E 1  3   4 
Total  81 20 14 7 44 166 
A-Angiotensin II receptor blocker; B-β-blockers; C-Calcium channel blockers; D-Diuretics; E-ACE-Inhibitors; F-α-blocker 
 
Table 7: Different class of drugs used in triple therapy 
Combination Dm Cva Cad Ccf Others Total 
C+E+D 1 2 1 1 1 6 
A+B+D   2  3 5 
B+C+D   2  1 3 
A+C+D 3 2   3 8 
A+D+E 1    1 2 
Total 5 4 5 1 9 24 
A-Angiotensin II receptor blocker; B-β-blockers; C-Calcium channel blockers; D-Diuretics; E-ACE-Inhibitor 
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Table 8: Different class of drugs used in quadruple therapy 
Combination Dm Cva Cad Ccf Others Total 
A+B+C+E  1   1 2 
A+C+D+E    1 1 2 
Total  1  1 2 4 
A-Angiotensin II receptor blocker; B-β-blockers; C-Calcium channel blockers; D-Diuretics; E-ACE-Inhibitors 
 
DISCUSSION 
In the present study, we classified the hypertensive patients based 
on drug therapy into four categories like patients on Monotherapy, 
dual, triple & quadruple therapies along with the various commonly 
observed comorbidities.  According to present study the compelling 
indication of HTN, diabetes mellitus 48.47% was most common, it 
was supported by Preethi et al.[6]., the study found that diabetes 
mellitus 38.71% was most common. 
According to the joint national committee (JNC) 7 guidelines these are 
the preferred class of drugs for patients with different compelling 
indications like diabetes mellitus, stroke and coronary artery disease. 
In the present study, the same was observed, i.e., irrespective of co 
morbidity and combination therapy calcium channel blockers and 
angiotensin II receptor blockers were most commonly prescribed. 
In the present study, monotherapy was given in almost 200 
(50.76%) patients prescribed with CCBs (25.38%) followed by ARBs 
(16.49%), beta-blockers (5.58%) and ACE inhibitors (3.2%) these 
results supported by Mohammad Arief et al.[7]., study found that 
among 400 patients, 351 patients received monotherapy and only 
49 patients received a combination therapy. Contrary evidence 
emerged out of major studies like blood pressure-lowering arm of 
the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT-BPLA) and 
national institute for health and excellence(NICE) which suggested 
that beta blockers are less effective than ACE inhibitors or CCBs in 
reducing the risk of DM and stroke Sharminder Kaur et al. [8]. 
Present study dual drug therapy was given in 166 (42.13%) patients 
and the most commonly prescribed dual therapy regimen were 
angiotensin II receptor blockers+calcium channel blockers in 
27.71% followed by β blockers+calcium channel blockers in 20.48% 
and calcium channel blockers+diuretics in 19.27% along with 
different combinations but Anand Kale et al.[9]., the study found that 
two-drug combinations, a diuretic with angiotensin receptor blocker 
(29.5%) was most commonly prescribed followed by a ß blocker 
with a calcium channel blocker (22.1 %). 
Triple therapy was used only in 24 (6.09%) patients most commonly 
prescribed triple therapy regimens were angiotensin II receptor 
blockers+calcium channel blockers+diuretics in 33.3% followed by 
angiotensin II receptor blockers+angiotensin converting enzyme 
inhibitors+diuretics in 25% but Preethi et al.[6]., the study reported 
ACE inhibitors, β-blocker and loop diuretics combination was mostly 
prescribed 25.54% and Angiotensin II receptor blockers, β-blocker 
and ACE inhibitors combination was given least preference 27%. 
Usage of four drugs is uncommon, and only 1.01% patients were 
prescribed four drug combinations, these results supported by 
Preethi et al. [6]. 
RanjeetaKumari et al.[3]., the study reveals that despite all the 
efforts taken by the government and the WHO, the pattern of 
prescription in terms of completeness and rationality remains poor. 
There is an urgent need to develop standards of drug prescription 
and develop ways and means to ensure that they are adhered to. 
Special attention needs to be given to the primary and secondary 
level health facilities, where significant irrational prescribing in 
terms of polypharmacy and the relative absence of the directions 
about the use of drugs was evident. This could be done by making it 
mandatory for the prescribers to attend regular continuing medical 
education (CME), so as to update their knowledge.
We conclude that calcium channel blockers and angiotensin II 
receptor blockers were the most commonly prescribed drugs either 
alone or in combination with other class of drugs for effective 
control of blood pressure in different comorbid conditions. Calcium 
channel blockers (CCBs) may be useful to diabetics, particularly as 
part of combination therapy to control BP as well as reduce the risk 
of cardiovascular disease (CVD) events in diabetics. Angiotensin II 
receptor blockers (ARBs) are more effective in slowing the 
progression of chronic kidney disease (CKD) than other 
antihypertensive regimens. Monotherapy was preferred than 
combination therapy. These two classes of drugs reduce the 
complications associated with hypertension. Prescribing patterns of 
antihypertensive drugs were in concordance with joint national 
committee (JNC) 7 guidelines for patients with different compelling 
indications. 
ABBREVIATION 
DM: Diabetes mellitus, CVA: Cerebrovascular accident, CVD: 
Cardiovascular disease, PVD: Peripheral vascular disease, CAD: 
Coronary artery disease, CCF: Congestive cardiac failure, CKD: 
Chronic kidney disease, JNC: Joint national committee, CCBs: Calcium 
channel blockers, ARBs: Angiotensin receptor blockers, ASCOT-
BPLA: Blood pressure-lowering arm of the, Anglo-Scandinavian 
Cardiac Outcomes Trial, NICE: National institute for health and 
excellences, WHO: World health organization, CME: Continuing 
medical education 
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